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Identity 
Other names: MPS-1, MPS1, S27 
HGNC (Hugo): RPS27 
Location: 1q21.3 
Local order: Human RPS27 is found on chromosome 
1: 153963235 - 153964626 bp from pter. Information 
about the local order for RPS27 can be found at 
ensembl.org. Four transcripts have been identified, but 
only the first will be discussed below. 
DNA/RNA 
Description 
The RPS27 gene is comprised of 1.39 kb and consists 
of 4 exons. This gene is a member of the Human CCDS 
set: CCDS1059. 
Transcription 
The transcript is 350 base pairs long. 
Pseudogene 
Multiple RPS27 pseudogenes are dispersed throughout 
the genome. The RPS27L pseudogene, located at 
15q22.2, is known to encode a protein that shares 96%
of its amino acid sequence with RPS27 
(Balasubramanian et al., 2009). 
Protein 
Description 
RPS27 is a 9461 Da protein composed of 84 amino 
acids. The protein contains a C4 zinc finger  
 
 
domain, similar to steroid and thyroid hormones, which 
enables DNA binding. RPS27 is found in both the 
cytoplasm and the nucleus. 
Expression 
Ubiquitous expression. Expressed at high levels in 
actively dividing cells and in cancers of ectodermal 
origin, as well as in melanoma (Fernandez-Pol et al., 
1993). When overexpressed, it is secreted into serum 
(Lee et al., 2004). 
Function 
1. Component of the 40S ribosomal subunit in the 
cytoplasm: ribosomes carry out translation of proteins. 
The eukaryotic ribosome is made up of a small 40S and 
a large 60S subunit. Together these subunits are 
comprised of 4 different rRNA species and almost 80 
different RP's (ribosomal proteins). As a component of 
the 40S subunit, RPS27 is found near RPS18 and 
covalently bound to translation initiation factor eIF3.  
2. A mediator of cellular proliferation and survival: 
expression is induced by a variety of growth factors 
and other signaling molecules, including TGF-beta and
cAMP; RPS27 can bind to cAMP response elements of 
DNA (Fernandez-Pol et al., 1993).  
3. Oncogenesis (see below). 
Homology 
Member of the ribosomal protein S27e family. 
Mutations 
Note 
Single nucleotide polymorphisms have been identified, 
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Implicated in 
Various carcinomas and melanoma 
Note 
RPS27 overexpression has been reported in many 
cancers including prostate cancer (Fernandez-Pol et al., 
1997), colorectal cancer (Ganger et al., 1997), liver 
cancer (Ganger et al., 2001), breast cancer (Atsuta et 
al., 2002), head and neck squamous cell cancer 
(HNSCC) (Stack et al., 1999; Stack et al., 2004; Lee et 
al., 2004), gastric cancer (Wang, et al., 2006), as well 
as, melanoma (Santa Cruz et al., 1997). 
Since high serum levels of RPS27 have been found in 
cancer patients, especially in head and neck squamos 
cell carcinoma (HNSCC), the protein can be used as a
tumor marker (Fernandez-Pol et al., 1996; Lee et al., 
2004; Stack et al. 2004). 
Prognosis 
It was reported that RPS27 levels correlate with tumor 
stage in patients with gastric cancer, thus high levels 
serve as a poor prognostic indicator (Wang et al., 
2006). 
Oncogenesis 
The mechanism behind RPS27 overexpression is 
currently under investigation. One explanation recently 
offered arises from the relationship between RPS27, 
MDM2 and p53: RPS27 is a p53 repressible protein 
(He and Sun, 2007; Li et al., 2007). A 2011 study 
found that it competes with p53 for a central acidic 
binding domain on MDM2. Once bound, MDM2 is 
stimulated to ubiquinate and degrade the RPS27 or p53, 
whichever it is bound to. When RPS27 levels are 
elevated, it can out-compete p53 for MDM2 binding 
and subsequent degradation, thus stabilizing p53 levels. 
This would be an appropriate cellular response to 
genotoxic stress. The same study also found that 
mutant p53 cannot suppress RPS27, only the wild-type 
can. Since mutated p53 is found in almost 50% of all 
human cancers, RPS27 overexpression logically 
follows. Furthermore, stabilization of mutant p53 levels 
associated with RPS27 abundance could provide 
malignant cells with a growth advantage (Xiong et al., 
2011).  
RPS27 knockdown was found to enhance spontaneous 
apoptosis of tumor cells via caspase-3 activation (Wang 
et al., 2006; Yang et al., 2011). 
HNSCC: some have questioned if RPS27 
overexpression is the cause or result of cancer. A 2010 
study overexpressed RPS27 in a line of HNSCC cells 
to study the impact on tumor behavior. They found that
RPS27 overexpression resulted in reduced cancer cell 
growth, proliferation rate and angiogenesis. RPS27 
overexpression was also found to reduce the mRNA of 
Paxillin, a focal adhesion protein up regulated in 
HNSCC and many other cancer cells. RPS27 induced 
Paxillin repression offers a possible explanation fr the 
decreased HNSCC growth (Dai et al., 2010). 
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